ES2098357T3 - Derivado de indol. - Google Patents
Derivado de indol.Info
- Publication number
- ES2098357T3 ES2098357T3 ES91911488T ES91911488T ES2098357T3 ES 2098357 T3 ES2098357 T3 ES 2098357T3 ES 91911488 T ES91911488 T ES 91911488T ES 91911488 T ES91911488 T ES 91911488T ES 2098357 T3 ES2098357 T3 ES 2098357T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- group
- carbonyl
- carbon atoms
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un procedimiento para preparar un derivado de indol representado por la **fórmula** en la cual R1 es un grupo alquilo C1-5, cicloalquil C4-7-alquilo, cicloalquenil C5-7-alquilo, aralquilo C7-14, trans-alquenilo C4-5, alilo, furanil-2-il-alquilo C1-5, tienil-2-il-alquilo C1-5, viniloxicarbonilo, tricloro-etoxicarbonilo, benciloxicarbonilo, alcanólo que tiene hasta 5 átomos de carbono, aralquil C7-14-carbonilo, 2-furólo, tiofeno-2-carbonilo, cicloalquil C4-7-carbonilo, alquenil C3-8-carbonilo, o anisólo,R2 es un átomo de hidrógeno o un grupo alquilo C1-3, bencilo o alcanólo que tiene hasta 5 átomos de carbono, R3 es un átomo de hidrógeno, fluor,cloro o bromo o ungruponitro o alquilo C1-5, R4 es un átomo de hidrógeno o un grupo alquilo C1-5, bencilo o fenilo, y R5 es un átomo de hidrógeno o un grupo hidroxi o alcanoiloxi que tiene hasta 5 átomos de carbono, y en el cual la fórmula general (1) abarca una forma (+), una forma (-) y una forma (+-) o una de sus sales farmacológicamente aceptables.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14817990 | 1990-06-05 | ||
JP33545890 | 1990-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2098357T3 true ES2098357T3 (es) | 1997-05-01 |
Family
ID=26478480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91911488T Expired - Lifetime ES2098357T3 (es) | 1990-06-05 | 1991-06-05 | Derivado de indol. |
Country Status (9)
Country | Link |
---|---|
US (2) | US5244904A (es) |
EP (2) | EP0735026A1 (es) |
JP (1) | JP3180344B2 (es) |
KR (1) | KR950002885B1 (es) |
CA (2) | CA2064853C (es) |
DE (1) | DE69125099T2 (es) |
ES (1) | ES2098357T3 (es) |
FI (1) | FI920480A0 (es) |
WO (1) | WO1991018901A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100241662B1 (ko) * | 1991-07-05 | 2000-03-02 | 지오르지오 스치니나 | 히드로이소퀴놀린 유도체 |
FR2697850B1 (fr) * | 1992-11-10 | 1994-12-02 | Univ Pasteur | Nouveaux polypeptides ayant une activité de récepteur opioïde, acides nucléiques codant pour ces polypeptides et utilisations. |
US5464841A (en) * | 1993-11-08 | 1995-11-07 | Univ Minnesota | Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
US5578725A (en) * | 1995-01-30 | 1996-11-26 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
AU6470996A (en) * | 1995-07-20 | 1997-02-18 | Toray Industries, Inc. | 4a-aryldecahydroisoquinoline compounds and medicinal uses thereof |
US5994327A (en) * | 1995-11-17 | 1999-11-30 | Astra Ab | Process for the preparation of morphinans |
US7232829B2 (en) * | 2001-04-06 | 2007-06-19 | Regents Of The University Of Minnesota | Therapeutic compounds and methods |
CA2474306A1 (en) * | 2002-01-25 | 2003-08-07 | Regents Of The University Of Minnesota | Selective analgesic agents |
EP2583678A3 (en) | 2004-06-24 | 2013-11-13 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
WO2006045096A2 (en) * | 2004-10-20 | 2006-04-27 | Resverlogix Corp. | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
JP5368792B2 (ja) | 2005-07-29 | 2013-12-18 | レスバーロジックス コーポレイション | 複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達 |
EP2118074B1 (en) | 2007-02-01 | 2014-01-22 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
KR101629356B1 (ko) | 2008-06-26 | 2016-06-13 | 리스버로직스 코퍼레이션 | 퀴나졸리논 유도체의 제조방법 |
EP2660238B1 (en) | 2009-01-08 | 2015-05-06 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular disease |
NZ617779A (en) | 2009-03-18 | 2015-08-28 | Resverlogix Corp | Novel anti-inflammatory agents |
ES2706651T3 (es) | 2009-04-22 | 2019-03-29 | Resverlogix Corp | Nuevos agentes antiinflamatorios |
CA2851996C (en) | 2011-11-01 | 2020-01-07 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
US9271978B2 (en) | 2012-12-21 | 2016-03-01 | Zenith Epigenetics Corp. | Heterocyclic compounds as bromodomain inhibitors |
JO3789B1 (ar) | 2015-03-13 | 2021-01-31 | Resverlogix Corp | التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة |
MA51738A (fr) | 2018-02-05 | 2021-05-12 | Alkermes Inc | Composés pour le traitement de la douleur |
US20230146716A1 (en) | 2021-10-14 | 2023-05-11 | Biosense Webster (Israel) Ltd. | Digital twin of atria for atrial fibrillation patients |
US20240020926A1 (en) | 2022-07-14 | 2024-01-18 | Biosense Webster (Israel) Ltd. | Correcting a segmentation curve in an anatomical model |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2351599A1 (de) * | 1972-07-20 | 1974-01-31 | Du Pont | 4a-aryl-trans-decahydrochinoline und verfahren zu ihrer herstellung |
US4419517A (en) * | 1973-06-01 | 1983-12-06 | E. I. Du Pont De Nemours & Co. | 4a-Aryl-trans-decahydroisoquinolines |
US3933827A (en) * | 1974-10-29 | 1976-01-20 | Hoffmann-La Roche Inc. | 9-Acyloxy-5,11-dimethyl-6H-pyrido[4,3-B]carbazoles |
US4310667A (en) * | 1976-04-22 | 1982-01-12 | Agence Nationale De Valorisation De La Recherche (Anvar) | 2-N Quaternary ammonium salt derivatives of 9-hydroxy ellipticine |
US4189583A (en) * | 1978-04-26 | 1980-02-19 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Synthesis of 4A-aryl-decahydroisoquinolines |
FR2436786A1 (fr) * | 1978-09-21 | 1980-04-18 | Anvar | Nouveaux derives des pyrido (4,3-b) carbazoles (ellipticines), substitues en position 1 par une chaine polyaminee, leur obtention et leur application a titre de medicaments |
-
1991
- 1991-06-05 JP JP51010991A patent/JP3180344B2/ja not_active Expired - Fee Related
- 1991-06-05 CA CA002064853A patent/CA2064853C/en not_active Expired - Fee Related
- 1991-06-05 EP EP96107563A patent/EP0735026A1/en not_active Withdrawn
- 1991-06-05 KR KR1019920700247A patent/KR950002885B1/ko not_active IP Right Cessation
- 1991-06-05 WO PCT/JP1991/000759 patent/WO1991018901A1/ja active IP Right Grant
- 1991-06-05 ES ES91911488T patent/ES2098357T3/es not_active Expired - Lifetime
- 1991-06-05 EP EP91911488A patent/EP0485636B1/en not_active Expired - Lifetime
- 1991-06-05 US US07/828,889 patent/US5244904A/en not_active Expired - Lifetime
- 1991-06-05 CA CA002224047A patent/CA2224047A1/en not_active Abandoned
- 1991-06-05 DE DE69125099T patent/DE69125099T2/de not_active Expired - Fee Related
-
1992
- 1992-02-04 FI FI920480A patent/FI920480A0/fi not_active Application Discontinuation
-
1993
- 1993-03-24 US US08/036,521 patent/US5539119A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2224047A1 (en) | 1991-12-06 |
KR920702360A (ko) | 1992-09-03 |
KR950002885B1 (ko) | 1995-03-28 |
CA2064853A1 (en) | 1991-12-06 |
WO1991018901A1 (fr) | 1991-12-12 |
EP0485636A4 (en) | 1992-11-19 |
DE69125099T2 (de) | 1997-06-19 |
FI920480A0 (fi) | 1992-02-04 |
EP0485636B1 (en) | 1997-03-12 |
JP3180344B2 (ja) | 2001-06-25 |
US5539119A (en) | 1996-07-23 |
EP0735026A1 (en) | 1996-10-02 |
EP0485636A1 (en) | 1992-05-20 |
US5244904A (en) | 1993-09-14 |
DE69125099D1 (de) | 1997-04-17 |
CA2064853C (en) | 1999-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2098357T3 (es) | Derivado de indol. | |
FI960751A (fi) | Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi | |
GR77595B (es) | ||
PE2799A1 (es) | Lactamas e imidas heterociclicas de aralquilo y aralquilideno | |
AU557691B2 (en) | 2-penem antibiotics and their oxa-aza-, and carba analogues | |
EA200101194A1 (ru) | Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств | |
DE3268225D1 (de) | 9-(2-(3-indolyl)ethyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones | |
CO4990965A1 (es) | Derivados de 1,3,8-triazaspiro(4,5)decan-4-ona to que los contiene y un proceso para la preparacion de es- tos derivados | |
SE8403801D0 (sv) | Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem | |
AR240823A2 (es) | Procedimiento de preparacion de una cefalosporina | |
SE7903450L (sv) | Nya substituerade 1,3-diaryl-2-imino-imidazolidiner och -2-imino-hexahydro-pyrimidiner och sett for framstellning derav | |
ATE128139T1 (de) | Neue methylenbisphosphonsäurederivate. | |
DK0383686T3 (da) | Carboxyalkylethere af 2-amino-7-hydroxytetralin samt fremgangsmåde til fremstilling deraf | |
CO4970804A1 (es) | Nuevos derivados de la vitamina d3 | |
AR004675A1 (es) | Nuevos compuestos antagonistas de receptores de endotelina, procedimiento para prepararlos, composiciones farmaceuticas que los contienen yprocedimiento para preparar estas composiciones farmaceuticas. | |
GR79170B (es) | ||
ECSP941143A (es) | Indoles | |
GB2001061A (en) | alpha -Vinyl Amino Acids | |
ATE108769T1 (de) | Verfahren zur herstellung von phenylsulfonamiden. | |
ES2059261A1 (es) | Alquil-bisacilfosfinoxidos. | |
ES2113382T3 (es) | Derivados de azetidinona y procedimiento para producir derivados de azetidinona y cefalosporina. | |
CO4970778A1 (es) | Nuevos compuestos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 485636 Country of ref document: ES |